{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:45:19Z","timestamp":1794217519548,"version":"4.8.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DA034637"],"award-info":[{"award-number":["1R01DA034637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DA011041"],"award-info":[{"award-number":["P30 DA011041"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1807-5","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T12:00:29Z","timestamp":1473076829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Daniel J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashly E.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"key":"1807_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: New estimates of age\u2010specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333\u201342.","journal-title":"Hepatology"},{"key":"1807_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","volume":"12","author":"J Grebely","year":"2012","unstructured":"Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, et al. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis. 2012;12:408\u201314.","journal-title":"Lancet Infect Dis"},{"key":"1807_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/jama.2011.975","volume":"306","author":"C Hadigan","year":"2011","unstructured":"Hadigan C, Kottilil S. Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management. JAMA. 2011;306:294\u2013301.","journal-title":"JAMA"},{"key":"1807_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","volume":"10","author":"B Hajarizadeh","year":"2013","unstructured":"Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10:553\u201362.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1807_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1086\/649783","volume":"201","author":"H Hagan","year":"2010","unstructured":"Hagan H, Pouget ER, Williams IT, Garfein RL, Strathdee SA, Hudson SM, et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis. 2010;201:378\u201385.","journal-title":"J Infect Dis"},{"key":"1807_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","volume":"378","author":"PK Nelson","year":"2011","unstructured":"Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571\u201383.","journal-title":"Lancet"},{"key":"1807_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.drugalcdep.2015.03.039","volume":"152","author":"AE Jordan","year":"2015","unstructured":"Jordan AE, Des Jarlais DC, Arasteh K, McKnight C, Nash D, Perlman DC. Incidence and prevalence of hepatitis C virus infection among persons who inject drugs in New York City: 2006\u20132013. Drug Alcohol Depend. 2015;152:194\u2013200.","journal-title":"Drug Alcohol Depend"},{"key":"1807_CR8","first-page":"423","volume":"67","author":"H Hagan","year":"2000","unstructured":"Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med. 2000;67:423\u20138.","journal-title":"Mt Sinai J Med"},{"key":"1807_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2012.06.010","volume":"57","author":"V Hernando","year":"2012","unstructured":"Hernando V, Perez-Cachafeiro S, Lewden C, Gonzalez J, Segura F, Oteo JA, et al. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. J Hepatol. 2012;57:743\u201351.","journal-title":"J Hepatol"},{"key":"1807_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.gastro.2012.12.026","volume":"144","author":"J van der Helm","year":"2013","unstructured":"van der Helm J, Geskus R, Sabin C, Meyer L, Del Amo J, Ch\u00eane G, et al. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. Gastroenterology. 2013;144:751\u201360.","journal-title":"Gastroenterology"},{"key":"1807_CR11","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1093\/infdis\/jis764","volume":"207","author":"MS Sulkowski","year":"2013","unstructured":"Sulkowski MS. Current management of hepatitis C virus infection in patients with HIV co-infection. J Infect Dis. 2013;207:S26\u201332.","journal-title":"J Infect Dis"},{"key":"1807_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1055\/s-0031-1297923","volume":"31","author":"MJ Alter","year":"2011","unstructured":"Alter MJ. HCV routes of transmission: what goes around comes around. Semin Liver Dis. 2011;31:340\u20136.","journal-title":"Semin Liver Dis"},{"key":"1807_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.3184","volume":"19","author":"DL Thomas","year":"2013","unstructured":"Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med. 2013;19:850\u20138.","journal-title":"Nat Med"},{"key":"1807_CR14","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1097\/QAD.0000000000000834","volume":"29","author":"H Hagan","year":"2015","unstructured":"Hagan H, Jordan AE, Neurer J, Cleland CM. Incidence of sexually transmitted hepatitis C virus infection in HIV-positive MSM: a systematic review and meta-analysis. AIDS. 2015;29:2335\u201345.","journal-title":"AIDS"},{"key":"1807_CR15","doi-asserted-by":"crossref","unstructured":"Jordan AE, Perlman DC, Neurer J, Smith DJ, Des Jarlais DC, Hagan H. Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: A systematic review and meta-analysis. Int J STD AIDS. 2016; In press.","DOI":"10.1177\/0956462416630910"},{"key":"1807_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2046-4053-3-31","volume":"3","author":"H Hagan","year":"2014","unstructured":"Hagan H, Neurer J, Jordan AE, Des Jarlais DC, Wu J, Dombrowski K, et al. Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysis. Syst Rev. 2014;3:31\u20137.","journal-title":"Syst Rev"},{"key":"1807_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/2046-4053-3-95","volume":"3","author":"AE Jordan","year":"2014","unstructured":"Jordan AE, Jarlais DD, Hagan H. Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis. Syst Rev. 2014;3:95\u20139.","journal-title":"Syst Rev"},{"key":"1807_CR18","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.2196\/resprot.4518","volume":"4","author":"J Combellick","year":"2015","unstructured":"Combellick J, Smith DJ, Jordan AE, Hagan H. Hepatitis C virus disease progression in people who inject drugs: protocol for a systematic review and meta-analysis. JMIR Res Protoc. 2015;4:e68.","journal-title":"JMIR Res Protoc"},{"key":"1807_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","volume":"26","author":"DJ Smith","year":"2015","unstructured":"Smith DJ, Combellick J, Jordan AE, Hagan H. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): a systematic review and meta-analysis. Int J Drug Policy. 2015;26:911\u201321.","journal-title":"Int J Drug Policy"},{"key":"1807_CR20","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"1807_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2009.11.009","volume":"14","author":"HS Te","year":"2010","unstructured":"Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14:1\u201321.","journal-title":"Clin Liver Dis"},{"key":"1807_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4254\/wjh.v4.i3.74","volume":"4","author":"E Franco","year":"2012","unstructured":"Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol. 2012;4:74\u201380.","journal-title":"World J Hepatol"},{"key":"1807_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1742-6405-7-3","volume":"7","author":"KA Johansson","year":"2010","unstructured":"Johansson KA, Robberstad B, Norheim OF. Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. AIDS Res Ther. 2010;7:3.","journal-title":"AIDS Res Ther"},{"key":"1807_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAD.0b013e328343443b","volume":"25","author":"European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel","year":"2011","unstructured":"European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS treatment network (NEAT) consensus conference. AIDS. 2011;25:399\u2013409.","journal-title":"AIDS"},{"key":"1807_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","volume":"144","author":"JA Hayden","year":"2006","unstructured":"Hayden JA, C\u00f4t\u00e9 P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144:427\u201337.","journal-title":"Ann Intern Med"},{"key":"1807_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"J Hayden","year":"2013","unstructured":"Hayden J, van der Windt D, Cartwright J, C\u00f4t\u00e9 P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280\u20136.","journal-title":"Ann Intern Med"},{"key":"1807_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"J Higgins","year":"2003","unstructured":"Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"1807_CR28","volume-title":"Stata statistical software: release 13","author":"StataCorp","year":"2013","unstructured":"StataCorp. Stata statistical software: release 13. College Station: StataCorp LP; 2013."},{"key":"1807_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.26639","volume":"59","author":"J Grebely","year":"2014","unstructured":"Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59:109\u201320.","journal-title":"Hepatology"},{"key":"1807_CR30","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1093\/cid\/cit306","volume":"15","author":"EJ Aspinall","year":"2013","unstructured":"Aspinall EJ, Corson S, Doyle JS, Grebely J, Hutchinson SJ, Dore GJ, et al. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis. 2013;15:S80\u20139.","journal-title":"Clin Infect Dis"},{"key":"1807_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/gut.2005.078147","volume":"55","author":"I Bakr","year":"2006","unstructured":"Bakr I, Rekacewicz C, Hosseiny ME, Ismail S, El Daly M, El-Kafrawy S, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006;55:1183\u20137.","journal-title":"Gut"},{"key":"1807_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","volume":"13","author":"JM Micallef","year":"2006","unstructured":"Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006;13:34\u201341.","journal-title":"J Viral Hepat"},{"key":"1807_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2008.06.005","volume":"49","author":"GV Matthews","year":"2008","unstructured":"Matthews GV, Grebely J, Dore GJ. The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure. J Hepatol. 2008;49:305\u20137.","journal-title":"J Hepatol"},{"key":"1807_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jcv.2005.12.010","volume":"36","author":"JH Aberle","year":"2006","unstructured":"Aberle JH, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, Perstinger G, et al. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol. 2006;36:24\u201331.","journal-title":"J Clin Virol"},{"key":"1807_CR35","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/hep.22534","volume":"48","author":"CK Aitken","year":"2008","unstructured":"Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, et al. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology. 2008;48:1746\u201352.","journal-title":"Hepatology"},{"key":"1807_CR36","doi-asserted-by":"publisher","first-page":"e97022","DOI":"10.1371\/journal.pone.0097022","volume":"9","author":"M Alanko Blom\u00e9","year":"2014","unstructured":"Alanko Blom\u00e9 M, Bj\u00f6rkman P, Molnegren V, H\u00f6glund P, Widell A. Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugs. PLoS One. 2014;9:e97022.","journal-title":"PLoS One"},{"key":"1807_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.drugalcdep.2011.06.005","volume":"119","author":"B Boodram","year":"2011","unstructured":"Boodram B, Hershow RC, Cotler SJ, Ouellet LJ. Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users. Drug Alcohol Depend. 2011;119:166\u201371.","journal-title":"Drug Alcohol Depend"},{"key":"1807_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0399-8320(04)95008-7","volume":"28","author":"M Cournot","year":"2004","unstructured":"Cournot M, Glibert A, Castel F, Druart F, Imani K, Lauwers-Cances V, et al. Management of hepatitis C in active drugs users: experience of an addiction care hepatology unit. Gastroenterol Clin Biol. 2004;28:533\u20139.","journal-title":"Gastroenterol Clin Biol"},{"key":"1807_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drugalcdep.2007.09.011","volume":"93","author":"SL Currie","year":"2008","unstructured":"Currie SL, Ryan JC, Tracy D, Wright TL, George S, McQuaid R, et al. A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus. Drug Alcohol Depend. 2008;93:148\u201354.","journal-title":"Drug Alcohol Depend"},{"key":"1807_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10654-009-9421-0","volume":"25","author":"K Dolan","year":"2010","unstructured":"Dolan K, Teutsch S, Scheuer N, Levy M, Rawlinson W, Kaldor J, et al. Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur J Epidemiol. 2010;25:143\u20138.","journal-title":"Eur J Epidemiol"},{"key":"1807_CR41","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.3748\/wjg.14.1878","volume":"14","author":"RJ Garten","year":"2008","unstructured":"Garten RJ, Lai SH, Zhang JB, Liu W, Chen J, Yu XF. Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China. World J Gastroenterol. 2008;14:1878\u201384.","journal-title":"World J Gastroenterol"},{"key":"1807_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","volume":"125","author":"JT Gerlach","year":"2003","unstructured":"Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology. 2003;125:80\u20138.","journal-title":"Gastroenterology"},{"key":"1807_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000068805","volume":"9","author":"SR Gjeruldsen","year":"2003","unstructured":"Gjeruldsen SR, Myrvang B, Opjordsmoen S. A 25-year follow-up study of drug addicts hospitalised for acute hepatitis: present and past morbidity. Eur Addict Res. 2003;9:80\u20136.","journal-title":"Eur Addict Res"},{"key":"1807_CR44","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1155\/2007\/796325","volume":"21","author":"J Grebely","year":"2007","unstructured":"Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol. 2007;21:447\u201351.","journal-title":"Can J Gastroenterol"},{"key":"1807_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.drugalcdep.2006.09.018","volume":"88","author":"R Hallinan","year":"2007","unstructured":"Hallinan R, Byrne A, Agho K, Dore GJ. Referral for chronic hepatitis C treatment from a drug dependency treatment setting. Drug Alcohol Depend. 2007;88:49\u201353.","journal-title":"Drug Alcohol Depend"},{"key":"1807_CR46","doi-asserted-by":"publisher","first-page":"e94791","DOI":"10.1371\/journal.pone.0094791","volume":"9","author":"MH Hsieh","year":"2014","unstructured":"Hsieh MH, Tsai JJ, Hsieh MY, Huang CF, Yeh ML, Yang JF, et al. Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection. PLoS One. 2014;9:e94791.","journal-title":"PLoS One"},{"key":"1807_CR47","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1086\/423943","volume":"190","author":"M Jauncey","year":"2004","unstructured":"Jauncey M, Micallef JM, Gilmour S, Amin J, White PA, Rawlinson W, et al. Clearance of hepatitis C virus after newly acquired infection in injection drug users. J Infect Dis. 2004;190:1270\u20134.","journal-title":"J Infect Dis"},{"key":"1807_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF03168517","volume":"174","author":"S Keating","year":"2005","unstructured":"Keating S, Coughlan S, Connell J, Sweeney B, Keenan E. Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area. Ir J Med Sci. 2005;174:37\u201341.","journal-title":"Ir J Med Sci"},{"key":"1807_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2012.08.024","volume":"58","author":"KB Kielland","year":"2013","unstructured":"Kielland KB, Skaug K, Amundsen EJ, Dalgard O. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33\u00a0years: a controlled study. J Hepatol. 2013;58:31\u20137.","journal-title":"J Hepatol"},{"key":"1807_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/00365540903062143","volume":"41","author":"C Lidman","year":"2009","unstructured":"Lidman C, Norden L, K\u00e5berg M, K\u00e4ll K, Franck J, Aleman S, et al. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender. Scand J Infect Dis. 2009;41:679\u201384.","journal-title":"Scand J Infect Dis"},{"key":"1807_CR51","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1600-0676.1993.tb00644.x","volume":"13","author":"L Mattsson","year":"1993","unstructured":"Mattsson L, S\u00f6nnerborg A, Weiland O. Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers. Liver. 1993;13:274\u20138.","journal-title":"Liver"},{"key":"1807_CR52","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1017\/S0950268806006820","volume":"135","author":"MF Meyer","year":"2007","unstructured":"Meyer MF, Wedemeyer H, Monazahian M, Dreesman J, Manns MP, Lehmann M. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol Infect. 2007;135:274\u201380.","journal-title":"Epidemiol Infect"},{"key":"1807_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","volume":"138","author":"WO Osburn","year":"2010","unstructured":"Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology. 2010;138:315\u201324.","journal-title":"Gastroenterology"},{"key":"1807_CR54","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1445-5994.1999.tb00779.x","volume":"29","author":"G Ostapowicz","year":"1999","unstructured":"Ostapowicz G, Bell SJ, Desmond PV. Severity of liver disease in hepatitis C infection contracted through injecting drug use. Aust N Z J Med. 1999;29:776\u201381.","journal-title":"Aust N Z J Med"},{"key":"1807_CR55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/cid\/cis921","volume":"56","author":"K Page","year":"2013","unstructured":"Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, et al. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis. 2013;56:405\u201313.","journal-title":"Clin Infect Dis"},{"key":"1807_CR56","doi-asserted-by":"publisher","first-page":"e23830","DOI":"10.1371\/journal.pone.0023830","volume":"6","author":"H Poustchi","year":"2011","unstructured":"Poustchi H, Esmaili S, Mohamadkhani A, Nikmahzar A, Pourshams A, Sepanlou SG, et al. The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study. PLoS One. 2011;6:e23830.","journal-title":"PLoS One"},{"key":"1807_CR57","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1086\/507640","volume":"43","author":"T Santantonio","year":"2006","unstructured":"Santantonio T, Medda E, Ferrari C, Fabris P, Cariti G, Massari M, et al. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis. 2006;43:1154\u20139.","journal-title":"Clin Infect Dis"},{"key":"1807_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jmv.22271","volume":"84","author":"DP Shah","year":"2012","unstructured":"Shah DP, Grimes CZ, Brown E, Hwang LY. Demographics, socio-behavioral factors, and drug use patterns: what matters in spontaneous HCV clearance? J Med Virol. 2012;84:235\u201341.","journal-title":"J Med Virol"},{"key":"1807_CR59","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jama.284.4.450","volume":"284","author":"DL Thomas","year":"2000","unstructured":"Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450\u20136.","journal-title":"JAMA"},{"key":"1807_CR60","doi-asserted-by":"publisher","first-page":"e27555","DOI":"10.1371\/journal.pone.0027555","volume":"6","author":"CH van den Berg","year":"2011","unstructured":"van den Berg CH, Grady BP, Schinkel J, van de Laar T, Molenkamp R, van Houdt R, et al. Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLoS One. 2011;6:e27555.","journal-title":"PLoS One"},{"key":"1807_CR61","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1086\/522608","volume":"196","author":"CC Wang","year":"2007","unstructured":"Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, et al. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis. 2007;196:1474\u201382.","journal-title":"J Infect Dis"},{"key":"1807_CR62","doi-asserted-by":"crossref","first-page":"19673","DOI":"10.2807\/ese.15.39.19673-en","volume":"15","author":"E Bottieau","year":"2010","unstructured":"Bottieau E, Apers L, Van Esbroeck M, Vandenbruaene M, Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001\u20132009. Euro Surveill. 2010;15:19673.","journal-title":"Euro Surveill"},{"key":"1807_CR63","first-page":"A97","volume":"17","author":"J Dietz","year":"2012","unstructured":"Dietz J, Lutz T, Knechi G, Gute P, Carlebach A, Grammatikos G, et al. Investigation of viral and host factors associated with outcome of acute hepatitis C in a cohort of patients with HIV coinfection. Antivir Ther. 2012;17:A97.","journal-title":"Antivir Ther"},{"key":"1807_CR64","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/cid\/cit799","volume":"58","author":"DS Fierer","year":"2014","unstructured":"Fierer DS, Dieterich DT, Mullen MP, Branch AD, Uriel AJ, Carriero DC, et al. Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men. Clin Infect Dis. 2014;58:873\u20139.","journal-title":"Clin Infect Dis"},{"key":"1807_CR65","doi-asserted-by":"publisher","first-page":"87s","DOI":"10.1177\/1055329003255815","volume":"14","author":"S Fletcher","year":"2003","unstructured":"Fletcher S. Sexual transmission of hepatitis C and early intervention. J Assoc Nurses AIDS Care. 2003;14:87s\u201394s.","journal-title":"J Assoc Nurses AIDS Care"},{"key":"1807_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.qai.0000174930.64145.a9","volume":"40","author":"YC Gilleece","year":"2005","unstructured":"Gilleece YC, Browne RE, Asboe D, Atkins M, Mandalia S, Bower M, et al. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J Acquir Immune Defic Syndr. 2005;40:41\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1807_CR67","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1097\/QAD.0b013e32836381cc","volume":"27","author":"TC Martin","year":"2013","unstructured":"Martin TC, Martin NK, Hickman M, Vickerman P, Page EE, Everett R, et al. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. AIDS. 2013;27:2551\u20137.","journal-title":"AIDS"},{"key":"1807_CR68","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/hep.23959","volume":"52","author":"L Piroth","year":"2010","unstructured":"Piroth L, Larsen C, Binquet C, Alric L, Auperin I, Chaix ML, et al. Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study. Hepatology. 2010;52:1915\u201321.","journal-title":"Hepatology"},{"key":"1807_CR69","doi-asserted-by":"publisher","first-page":"S466","DOI":"10.1016\/S0168-8278(11)61181-1","volume":"54","author":"J Sasadeusz","year":"2011","unstructured":"Sasadeusz J, Rodger A, Fernandez T, Bhagani S. High rates of sexually transmitted HCV re-infection in HIV positive men who have sex with men: prevention is the key [poster 1179]. J Hepatol. 2011;54:S466.","journal-title":"J Hepatol"},{"key":"1807_CR70","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/gut.2010.217166","volume":"60","author":"EC Thomson","year":"2011","unstructured":"Thomson EC, Fleming VM, Main J, Klenerman P, Weber J, Eliahoo J, et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut. 2011;60:837\u201345.","journal-title":"Gut"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1807-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1807-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T19:40:54Z","timestamp":1657222854000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1807-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1807-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]},"assertion":[{"value":"9 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"471"}}